Co-Authors
This is a "connection" page, showing publications co-authored by Verena Keitel and Wilfried Budach.
Connection Strength
0.357
-
Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial. Trials. 2021 May 17; 22(1):343.
Score: 0.236
-
Delayed skin reaction after mRNA-1273 vaccine against SARS-CoV-2: a rare clinical reaction. Eur J Med Res. 2021 Aug 25; 26(1):98.
Score: 0.060
-
Informed consent and informed intervention: SARS-CoV-2 vaccinations not just call for disclosure of newly emerging safety data but also for hypothesis generation and testing. Eur J Med Res. 2021 Aug 06; 26(1):87.
Score: 0.060